Influence of nifedipine coat-core and amlodipine on systemic arterial stiffness modulated by sympathetic and parasympathetic activity in hypertensive patients. 2009

Michinari Fukuda, and Takashi Masuda, and Misao N Ogura, and Tatsumi Moriya, and Keiji Tanaka, and Kazuya Yamamoto, and Akira Ishii, and Ryusuke Yonezawa, and Chiharu Noda, and Tohru Izumi
Department of Rehabilitation, Kitasato University School of Allied Health Sciences, Kanagawa, Japan.

The aim of this study was to compare the effects of nifedipine coat-core (once daily formulation) and amlodipine on systemic arterial stiffness in patients with hypertension. Study drugs were assigned by the randomized open-label crossover method. After the blood pressure was maintained below 130/85 mm Hg for 8 months by treatment with either drug in 48 hypertensive patients (aged 63.2+/-6.9 years; 64.5% men), they were switched to the other drug for another 8 months. The blood pressure, heart rate, plasma catecholamine level and brachial-ankle pulse wave velocity were measured before and after a bicycle ergometer testing. Heart rate recovery was calculated from the change of the heart rate after treadmill exercise testing. The high-frequency and low-frequency components of the heart rate variability spectrum were analyzed from 24-h Holter electrocardiograms. The change of blood pressure after exercise testing showed no significant difference between the two medications. However, the increases of heart rate, noradrenalin and branchial-ankle pulse wave velocity after exercise were significantly smaller with nifedipine treatment than with amlodipine (P=0.0472, P=0.006 and P=0.0472, respectively). Heart rate recovery was significantly faster with nifedipine treatment (P=0.0280). The nighttime high-frequency component of heart rate variability was significantly larger after nifedipine treatment than after amlodipine (P=0.0259), while the nighttime low/high-frequency ratio was significantly smaller with nifedipine (P=0.0429). Nifedipine reduced functional arterial stiffness and improved heart rate recovery by altering the autonomic activity balance in hypertensive patients.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D010275 Parasympathetic Nervous System The craniosacral division of the autonomic nervous system. The cell bodies of the parasympathetic preganglionic fibers are in brain stem nuclei and in the sacral spinal cord. They synapse in cranial autonomic ganglia or in terminal ganglia near target organs. The parasympathetic nervous system generally acts to conserve resources and restore homeostasis, often with effects reciprocal to the sympathetic nervous system. Nervous System, Parasympathetic,Nervous Systems, Parasympathetic,Parasympathetic Nervous Systems,System, Parasympathetic Nervous,Systems, Parasympathetic Nervous
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D005260 Female Females
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse

Related Publications

Michinari Fukuda, and Takashi Masuda, and Misao N Ogura, and Tatsumi Moriya, and Keiji Tanaka, and Kazuya Yamamoto, and Akira Ishii, and Ryusuke Yonezawa, and Chiharu Noda, and Tohru Izumi
November 2004, American journal of hypertension,
Michinari Fukuda, and Takashi Masuda, and Misao N Ogura, and Tatsumi Moriya, and Keiji Tanaka, and Kazuya Yamamoto, and Akira Ishii, and Ryusuke Yonezawa, and Chiharu Noda, and Tohru Izumi
January 1998, Journal of hypertension,
Michinari Fukuda, and Takashi Masuda, and Misao N Ogura, and Tatsumi Moriya, and Keiji Tanaka, and Kazuya Yamamoto, and Akira Ishii, and Ryusuke Yonezawa, and Chiharu Noda, and Tohru Izumi
January 1998, Clinical and experimental pharmacology & physiology,
Michinari Fukuda, and Takashi Masuda, and Misao N Ogura, and Tatsumi Moriya, and Keiji Tanaka, and Kazuya Yamamoto, and Akira Ishii, and Ryusuke Yonezawa, and Chiharu Noda, and Tohru Izumi
January 2017, Journal of clinical hypertension (Greenwich, Conn.),
Michinari Fukuda, and Takashi Masuda, and Misao N Ogura, and Tatsumi Moriya, and Keiji Tanaka, and Kazuya Yamamoto, and Akira Ishii, and Ryusuke Yonezawa, and Chiharu Noda, and Tohru Izumi
January 2003, Journal of cardiovascular pharmacology,
Michinari Fukuda, and Takashi Masuda, and Misao N Ogura, and Tatsumi Moriya, and Keiji Tanaka, and Kazuya Yamamoto, and Akira Ishii, and Ryusuke Yonezawa, and Chiharu Noda, and Tohru Izumi
February 2019, Journal of clinical hypertension (Greenwich, Conn.),
Michinari Fukuda, and Takashi Masuda, and Misao N Ogura, and Tatsumi Moriya, and Keiji Tanaka, and Kazuya Yamamoto, and Akira Ishii, and Ryusuke Yonezawa, and Chiharu Noda, and Tohru Izumi
September 1998, Journal of hypertension,
Michinari Fukuda, and Takashi Masuda, and Misao N Ogura, and Tatsumi Moriya, and Keiji Tanaka, and Kazuya Yamamoto, and Akira Ishii, and Ryusuke Yonezawa, and Chiharu Noda, and Tohru Izumi
November 1998, Journal of hypertension,
Michinari Fukuda, and Takashi Masuda, and Misao N Ogura, and Tatsumi Moriya, and Keiji Tanaka, and Kazuya Yamamoto, and Akira Ishii, and Ryusuke Yonezawa, and Chiharu Noda, and Tohru Izumi
January 2011, Clinical and experimental hypertension (New York, N.Y. : 1993),
Michinari Fukuda, and Takashi Masuda, and Misao N Ogura, and Tatsumi Moriya, and Keiji Tanaka, and Kazuya Yamamoto, and Akira Ishii, and Ryusuke Yonezawa, and Chiharu Noda, and Tohru Izumi
January 2000, Klinicheskaia meditsina,
Copied contents to your clipboard!